Breast cancer and serum ferritin - Menopausal status perspective: Menopause - A fickle determinant

Harshal P. Narkhede, Manohar G. Muddeshwar, Vishakha V. Mahajan


Background: Association of raised serum ferritin levels with breast carcinoma is a well established fact on account of iron enhanced free radical mediated oestrogen induced carcinogenesis. Previous literatures report variations in serum ferritin levels with menopause, especially indicating its association with metabolic syndrome in post-menopausal women. Seldom has any study focussed upon influence of age and menopausal status towards serum ferritin level determination in breast cancer patients. Assess an impact of age and menopausal status over serum ferritin levels in patients with breast cancer and in healthy females; and their comparisons.

Methods: Enzyme linked immuno-sorbent assay based estimation of serum ferritin was carried out in patients with breast carcinoma and healthy females. Objective: Age-wise and menopausal status-wise grouped numerical data were analyzed through intra- and inter-group comparisons.

Results: Higher serum ferritin levels were observed in all age groups as well as pre-menopausal and post-menopausal groups of breast cancer subjects than their respective groups among healthy subjects. No particular age or menopausal status-wise pattern could be identified among cases as well as healthy controls.

Conclusions: Serum ferritin levels abide no obvious influence of age or menopausal status in breast cancer patients as well as post-menopausal women devoid of metabolic syndrome. The present study reiterates the possible role of iron in breast carcinogenesis.



Breast cancer, Serum ferritin, Menopause, Metabolic syndrome

Full Text:



Marinova M, Vladimirova L. Atomic Absorption Assessment of Mineral Iron Quantity in Ferritin. Bulg J Phys. 2009;36:139-44.

Herbert V. Everyone should be tested for iron disorders. J Am Diet Assoc. 1992;92:1502-9.

Wyllie S, Liehr JG. Enhancement of estrogen-induced renal tumorigenesis in hamsters by dietary iron. Carcinogenesis. 1998;19(7):1285-90.

Ebina Y, Okada S, Hamazaki S, Ogino F, Li FJ, Midorikawa O. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst. 1986 Jan;76(1):107-13.

Jian J. Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid Redox Signal. 2009 Dec;11(12):2939-43.

Cho GJ. Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women. Menopause. 2011 Oct;18(10):1120-4.

Cho SH. Serum Ferritin and Metabolic Syndrome in Perimenopausal and Postmenopausal Women. J Korean Soc Menopause. 2011 Dec;17(3):166-73.

Alberti G, Zimmet P, Shaw J, Grundy SM. Worldwide definition for use in clinical practice. In: The IDF consensus worldwide definition of the metabolic syndrome. Belgium: International Diabetes Federeation; 2006: 10.

Kim C. Changes in iron measures over menopause and associations with insulin resistance. Journal of Women’s Health. 2012;21(8):1-6.

Liu JM. Body iron stores and their determinants in healthy postmenopausal US women. Am J Clin Nutr. 2003 Dec;78(6):1160-7.

Klipstein-Grobusch K, Koster JF, Grobbee DE, Lindemans J, Boeing H, Hofman A et al. Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam study. Am J Clin Nutr.1999 Jun;69(6):1231-6.

Li Y. Serum Ferritin Interacts with Menopausal Status in its Association with Blood Pressure in Adult Women: National Health and Nutrition Examination Survey (NHANES), 2001–2002. Circulation. 2006;114:II_875.

Jacobs A, Jones B, Ricketts C, Bulbrook RD, Wang DY. Serum ferritin concentration in early breast cancer. Br J Cancer 1976;34:286-90.

Mishra S, Sharma DC, Sharma P. Studies of biochemical parameters in breast cancer with and without metastasis. Indian J Clin Biochem. 2004;19(1):71-5.

Kher A, Moghe G, Deshpande A. Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast. Indian J Pathol Microbiol.1997 Jul;40(3):321-6.

Ulbrich EJ, Lebrecht A, Schneider I, Ludwig E, Koelbl H, Hefler LA. Serum parameters of iron metabolism in patients with breast cancer. Anticancer Res. 2003 Nov-Dec;23(6d):5107-9.

Moore AB. Dietary and stored iron as predictors of breast cancer risk: A nested case–control study in Shanghai. Int J Cancer. 2009 September;125(5):1110-7.

Goswami B, Tayal D, Mallika V. Ferritin: a multidimensional bio marker. Internet Journal of Laboratory Medicine. 2009;3(2).

Bae YJ. Dietary Intake and Serum Levels of Iron in Relation to Oxidative Stress in Breast Cancer Patients. J Clin Biochem Nutr. 2009 November;45(3):355-60.

Ferritin enzyme immunoassay reagent set [Kit insert]. Mountain View (CA): United Biotech Inc; 2008. Available at: